| First Author | Letai A | Year | 2005 |
| Journal | J Clin Invest | Volume | 115 |
| Issue | 10 | Pages | 2648-55 |
| PubMed ID | 16200198 | Mgi Jnum | J:101525 |
| Mgi Id | MGI:3604228 | Doi | 10.1172/JCI26250 |
| Citation | Letai A (2005) Pharmacological manipulation of Bcl-2 family members to control cell death. J Clin Invest 115(10):2648-55 |
| abstractText | The commitment to programmed cell death involves complex interactions among pro- and antiapoptotic members of the Bcl-2 family of proteins. The physiological result of a decision by these proteins to undergo cell death is permeabilization of the mitochondrial outer membrane. Pharmacologic manipulation of proteins in this family appears both feasible and efficacious, whether the goal is decreased cell death, as in ischemia of the myocardium or brain, or increased cell death, as in cancer. |
